Essential Characteristics of Pharmacogenomics Study Publications
- 8 November 2018
- journal article
- review article
- Published by Wiley in Cancer Cell
- Vol. 105 (1), 86-91
- https://doi.org/10.1002/cpt.1279
Abstract
Pharmacogenomics (PGx) can be seen as a model for biomedical studies: it includes all disease areas of interest, spans in vitro studies to clinical trials, while focusing on the relationships between genes and drugs and the resulting phenotypes. This review will examine different characteristics of PGx study publications and provide examples of excellence in framing PGx questions and reporting their resulting data in a way that maximizes the knowledge that can be built upon them.Keywords
Funding Information
- National Institutes of Health (CA21765, GM115279, GM 115264)
- National Institute of General Medical Sciences (GM61374, GM 115264, HG010135)
This publication has 45 references indexed in Scilit:
- Ethnicity-specific pharmacogenetics: the case of warfarin in African AmericansThe Pharmacogenomics Journal, 2013
- Characterization of the genetic variation present in CYP3A4 in three South African populationsFrontiers in Genetics, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol DosingClinical Pharmacology & Therapeutics, 2012
- Pharmacogene regulatory elements: from discovery to applicationsGenome Medicine, 2012
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkCancer Cell, 2011
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistanceProceedings of the National Academy of Sciences of the United States of America, 2007
- CYP2C9 , CYP2C19 and CYP2D6 Allele Frequencies in the Ashkenazi Jewish PopulationPharmacogenomics, 2007
- HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinolProceedings of the National Academy of Sciences of the United States of America, 2005
- Evidence based medicine: what it is and what it isn'tBMJ, 1996